HydroprotopineCAS# 128397-41-1 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 128397-41-1 | SDF | Download SDF |
PubChem ID | 14140130 | Appearance | Powder |
Formula | C20H20NO5 | M.Wt | 354.4 |
Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
SMILES | C[N+]12CCC3=CC4=C(C=C3C1(CC5=C(C2)C6=C(C=C5)OCO6)O)OCO4 | ||
Standard InChIKey | SZMZXQWCICMUFH-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C20H20NO5/c1-21-5-4-12-6-17-18(25-10-24-17)7-15(12)20(21,22)8-13-2-3-16-19(14(13)9-21)26-11-23-16/h2-3,6-7,22H,4-5,8-11H2,1H3/q+1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
In vitro | Application of chromatography technology in the separation of active alkaloids from Hypecoum leptocarpum and their inhibitory effect on fatty acid synthase.[Reference: WebLink]Journal of Separation Science, 2015, 38(23):4063-4070.
|
Hydroprotopine Dilution Calculator
Hydroprotopine Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.8217 mL | 14.1084 mL | 28.2167 mL | 56.4334 mL | 70.5418 mL |
5 mM | 0.5643 mL | 2.8217 mL | 5.6433 mL | 11.2867 mL | 14.1084 mL |
10 mM | 0.2822 mL | 1.4108 mL | 2.8217 mL | 5.6433 mL | 7.0542 mL |
50 mM | 0.0564 mL | 0.2822 mL | 0.5643 mL | 1.1287 mL | 1.4108 mL |
100 mM | 0.0282 mL | 0.1411 mL | 0.2822 mL | 0.5643 mL | 0.7054 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Hyptadienic acid
Catalog No.:BCN6154
CAS No.:128397-09-1
- MCH (human, mouse, rat)
Catalog No.:BCC6068
CAS No.:128315-56-0
- Cinalukast
Catalog No.:BCC7244
CAS No.:128312-51-6
- MK-8033 hydrochloride
Catalog No.:BCC4040
CAS No.:1283000-43-0
- 2alpha-Hydroxy-8beta-(2-methylbutyryloxy)costunolide
Catalog No.:BCN7319
CAS No.:128286-87-3
- Bivalirudin Trifluoroacetate
Catalog No.:BCC1421
CAS No.:128270-60-0
- 1-(3,4-Dimethoxycinnamoyl)piperidine
Catalog No.:BCN4036
CAS No.:128261-84-7
- Axillaridine A
Catalog No.:BCN6153
CAS No.:128255-16-3
- Pachyaximine A
Catalog No.:BCN6152
CAS No.:128255-08-3
- BAY-X 1005
Catalog No.:BCC6038
CAS No.:128253-31-6
- GDC-0032
Catalog No.:BCC4066
CAS No.:1282512-48-4
- (R,R)-2,6-Bis(4-phenyl-2-oxazolin-2-yl)pyridine
Catalog No.:BCC8397
CAS No.:128249-70-7
- Euojaponine D
Catalog No.:BCC8980
CAS No.:128397-42-2
- Gelidoside
Catalog No.:BCN7320
CAS No.:128420-44-0
- 2-Hydroxypropyl-β-cyclodextrin
Catalog No.:BCC6757
CAS No.:128446-35-5
- Methylophioponanone B
Catalog No.:BCN6525
CAS No.:128446-36-6
- Ophiogenin-3-O-alpha-L-rhaMnopyranosyl-(1→2)-beta-D-glucopyranoside
Catalog No.:BCN1587
CAS No.:128502-94-3
- Romidepsin (FK228, depsipeptide)
Catalog No.:BCC3597
CAS No.:128517-07-7
- GSK2578215A
Catalog No.:BCC6243
CAS No.:1285515-21-0
- ML167
Catalog No.:BCC5348
CAS No.:1285702-20-6
- Pingpeimine C
Catalog No.:BCN8411
CAS No.:128585-96-6
- Ospemifene
Catalog No.:BCC5557
CAS No.:128607-22-7
- Z(2-Br)-Osu
Catalog No.:BCC2806
CAS No.:128611-93-8
- PyBOP
Catalog No.:BCC2820
CAS No.:128625-52-5
Application of chromatography technology in the separation of active alkaloids from Hypecoum leptocarpum and their inhibitory effect on fatty acid synthase.[Pubmed:26544947]
J Sep Sci. 2015 Dec;38(23):4063-70.
A method that involved the combination of pH-zone-refining counter-current chromatography and semipreparative reversed-phase liquid chromatography has been established for the preparative separation of alkaloids from Hypecoum leptocarpum. From 1.2 g of crude sample, 31 mg N-feruloyltyramine, 27 mg oxohydrastinine, 47 mg Hydroprotopine, 25 mg leptopidine, and 18 mg hypecocarpine have been obtained. The structure of the new compound, hypecocarpine, is confirmed based on the analysis of spectroscopic data, including NMR, UV, and IR spectroscopy and positive electrospray ionization mass spectrometry. The known chemical structures were characterized on the basis of (1) H and (13) C NMR spectroscopy. The purities of the five alkaloids are all over 92.7% as determined by high-performance liquid chromatography. The alkaloids' cytotoxicity in breast cancer cells is assessed by using a Cell Counting Kit assay and their inhibitory effect on fatty acid synthase expression is assessed by a Western blot assay. These results suggest that leptopidine could suppress growth and induce cytotoxicity in breast cancer cells and that the cytotoxicity of leptopidine may be related to its inhibitory effect on fatty acid synthase expression.